|
RCOR3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.546000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.609400E-01 |
| Normal-vs-Stage2 |
4.841800E-01 |
| Normal-vs-Stage3 |
2.842800E-01 |
| Normal-vs-Stage4 |
7.014200E-02 |
| Stage1-vs-Stage2 |
5.323400E-01 |
| Stage1-vs-Stage3 |
1.991780E-01 |
| Stage1-vs-Stage4 |
3.040000E-02 |
| Stage2-vs-Stage3 |
1.783040E-01 |
| Stage2-vs-Stage4 |
6.604000E-02 |
| Stage3-vs-Stage4 |
4.128800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.738600E-01 |
| Normal-vs-AfricanAmerican |
7.680400E-01 |
| Normal-vs-Asian |
3.708000E-02 |
| Caucasian-vs-AfricanAmerican |
9.449600E-01 |
| Caucasian-vs-Asian |
1.026650E-01 |
| AfricanAmerican-vs-Asian |
8.526300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.962600E-01 |
| Normal-vs-Female |
7.387000E-01 |
| Male-vs-Female |
1.966020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.400000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.536200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.991800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.855000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.824800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.589400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.609800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.398440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.744800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.258200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.455400E-03 |
| Normal-vs-Grade 2 |
3.138600E-01 |
| Normal-vs-Grade 3 |
4.988400E-01 |
| Normal-vs-Grade 4 |
6.46890000000067E-05 |
| Grade 1-vs-Grade 2 |
1.182750E-01 |
| Grade 1-vs-Grade 3 |
9.956400E-03 |
| Grade 1-vs-Grade 4 |
2.58369999994734E-06 |
| Grade 2-vs-Grade 3 |
6.641600E-02 |
| Grade 2-vs-Grade 4 |
2.02980000030273E-07 |
| Grade 3-vs-Grade 4 |
1.604190E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.601300E-03 |
| Normal-vs-ccB subtype |
3.541600E-03 |
| ccA subtype-vs-ccB subtype |
4.13029999091208E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.577000E-01 |
| Normal-vs-N1 |
4.327900E-02 |
| N0-vs-N1 |
4.792100E-02 |
|
|
